Pharmaceuticals (19) | Equity Distribution Agreements (19)

Browse by Company

Recent Contracts

Equity Distribution Agreement, dated September 1, 2021, by and between the Company and Cantor Fitzgerald & Co (ORAMED PHARMACEUTICALS INC., Filed With SEC on September 1, 2021)
Equity Distribution Agreement, dated August 20, 2021, by and among Processa Pharmaceuticals, Inc. and Oppenheimer & Co. Inc (Processa Pharmaceuticals, Inc., Filed With SEC on August 20, 2021)
Equity Distribution Agreement, dated as of August 20, 2021, between Onconova Therapeutics, Inc. and Piper Sandler & Co (Onconova Therapeutics, Inc., Filed With SEC on August 20, 2021)
Equity Distribution Agreement, dated August 6, 2021, by and among Arvinas, Inc., Piper Sandler & Co. and Cantor Fitzgerald & Co (ARVINAS, INC., Filed With SEC on August 6, 2021)
Equity Distribution Agreement, dated July 15, 2021, by and between the Company and Canaccord Genuity (ORAMED PHARMACEUTICALS INC., Filed With SEC on July 15, 2021)
Equity Distribution Agreement, dated July 2, 2021, by and among KemPharm, Inc., JMP Securities LLC and RBC Capital Markets, LLC (KEMPHARM, INC, Filed With SEC on July 2, 2021)
Equity Distribution Agreement, dated June 16, 2021, by and between the Company and Canaccord Genuity (ORAMED PHARMACEUTICALS INC., Filed With SEC on June 16, 2021)
Amendment No. 1 to the Equity Distribution Agreement, dated March 26, 2021, by and between Aquestive Therapeutics, Inc. and Piper Sandler & Co (Aquestive Therapeutics, Inc., Filed With SEC on March 26, 2021)
Letter amending the Standby Equity Distribution Agreement by and between the Institutional Investor and Acreage Holdings, Inc., dated March 11, 2021 (Acreage Holdings, Inc., Filed With SEC on March 26, 2021)
Equity Distribution Agreement, dated December 1, 2020, by and between the Company and Canaccord Genuity (ORAMED PHARMACEUTICALS INC., Filed With SEC on December 1, 2020)